Rafferty Asset Management
COLL icon

Rafferty Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Rafferty Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+5,708
New +$195K ﹤0.01% 1098
2026
Q1 		– Sell
-4,785
Closed -$222K – 1080
2025
Q4 		$222K Buy
+4,785
New +$200K ﹤0.01% 1075
2024
Q4 		– Sell
-6,225
Closed -$241K – 1148
2024
Q3 		$241K Sell
6,225
-81
-1% -$2.89K ﹤0.01% 1070
2024
Q2 		$203K Buy
+6,306
New +$219K ﹤0.01% 1139

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Rafferty Asset Management's COLL Position: Q2 2026 in Review

Rafferty Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 5,708 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1098 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in COLL as recently as Q4 2025.

Rafferty Asset Management first reported a position in COLL in Q2 2024 and has held it in 4 quarters since. The position peaked at $241K in Q3 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Rafferty Asset Management held 5,708 shares of Collegium Pharmaceutical worth $207K as of Q2 2026.
  • Collegium Pharmaceutical was a new Rafferty Asset Management position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1098 holding.
  • Rafferty Asset Management first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 4 quarters since.
  • Rafferty Asset Management's Collegium Pharmaceutical position peaked at $241K in Q3 2024.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.